These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. TGFbeta and cancer metastasis: an inflammation link. Yang L Cancer Metastasis Rev; 2010 Jun; 29(2):263-71. PubMed ID: 20437081 [TBL] [Abstract][Full Text] [Related]
9. Krüppel-like Transcription Factor KLF10 Suppresses TGFβ-Induced Epithelial-to-Mesenchymal Transition via a Negative Feedback Mechanism. Mishra VK; Subramaniam M; Kari V; Pitel KS; Baumgart SJ; Naylor RM; Nagarajan S; Wegwitz F; Ellenrieder V; Hawse JR; Johnsen SA Cancer Res; 2017 May; 77(9):2387-2400. PubMed ID: 28249899 [TBL] [Abstract][Full Text] [Related]
10. Role of transforming growth factor beta in breast carcinogenesis. Benson JR Lancet Oncol; 2004 Apr; 5(4):229-39. PubMed ID: 15050954 [TBL] [Abstract][Full Text] [Related]
11. Abrogation of transforming growth factor-beta signaling in pancreatic cancer. Lin X; Feng XH World J Surg; 2005 Mar; 29(3):312-6. PubMed ID: 15706432 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-1R-associated kinase 2 is a novel modulator of the transforming growth factor beta signaling cascade. Mullenders J; Fabius AW; van Dongen MM; Kuiken HJ; Beijersbergen RL; Bernards R Mol Cancer Res; 2010 Apr; 8(4):592-603. PubMed ID: 20332216 [TBL] [Abstract][Full Text] [Related]
13. The Retinoblastoma Tumor Suppressor Protein (pRb)/E2 Promoter Binding Factor 1 (E2F1) Pathway as a Novel Mediator of TGFβ-induced Autophagy. Korah J; Canaff L; Lebrun JJ J Biol Chem; 2016 Jan; 291(5):2043-54. PubMed ID: 26598524 [TBL] [Abstract][Full Text] [Related]
14. The Outcome of TGFβ Antagonism in Metastatic Breast Cancer Models Yang Y; Yang HH; Tang B; Wu AML; Flanders KC; Moshkovich N; Weinberg DS; Welsh MA; Weng J; Ochoa HJ; Hu TY; Herrmann MA; Chen J; Edmondson EF; Simpson RM; Liu F; Liu H; Lee MP; Wakefield LM Clin Cancer Res; 2020 Feb; 26(3):643-656. PubMed ID: 31582516 [TBL] [Abstract][Full Text] [Related]
15. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Bierie B; Moses HL Nat Rev Cancer; 2006 Jul; 6(7):506-20. PubMed ID: 16794634 [TBL] [Abstract][Full Text] [Related]
16. TGF‑β signaling: A complex role in tumorigenesis (Review). Liu S; Chen S; Zeng J Mol Med Rep; 2018 Jan; 17(1):699-704. PubMed ID: 29115550 [TBL] [Abstract][Full Text] [Related]
17. GATA3 transcription factor abrogates Smad4 transcription factor-mediated fascin overexpression, invadopodium formation, and breast cancer cell invasion. Sun J; He H; Pillai S; Xiong Y; Challa S; Xu L; Chellappan S; Yang S J Biol Chem; 2013 Dec; 288(52):36971-82. PubMed ID: 24235142 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of PIK3CA in murine head and neck epithelium drives tumor invasion and metastasis through PDK1 and enhanced TGFβ signaling. Du L; Chen X; Cao Y; Lu L; Zhang F; Bornstein S; Li Y; Owens P; Malkoski S; Said S; Jin F; Kulesz-Martin M; Gross N; Wang XJ; Lu SL Oncogene; 2016 Sep; 35(35):4641-52. PubMed ID: 26876212 [TBL] [Abstract][Full Text] [Related]
19. The TGFBeta pathway as a therapeutic target in cancer. Seoane J Clin Transl Oncol; 2008 Jan; 10(1):14-9. PubMed ID: 18208788 [TBL] [Abstract][Full Text] [Related]
20. Regulation of EMT by TGFβ in cancer. Heldin CH; Vanlandewijck M; Moustakas A FEBS Lett; 2012 Jul; 586(14):1959-70. PubMed ID: 22710176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]